Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 1201 AL 1215

Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline

Pettigrew C, Soldan A, Wang J, Wang MC, Arthur K, Moghekar A, Gottesman RF, Albert M.

Neurology. 2020 Dec 8;95(23):e3093-e3103. doi: 10.1212/WNL.0000000000010946. Epub 2020 Sep 28.

Alzheimer disease biomarker profiles in dementia with Lewy bodies: Does A plus T spell D-L-B?

Koyama AK, Irwin DJ.

Neurology. 2020 Dec 15;95(24):1076-1077. doi: 10.1212/WNL.0000000000010958. Epub 2020 Sep 28.

Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation

Liu Y, Li H, Wang J, Xue Q, Yang X, Kang Y, Li M, Xu J, Li G, Li C, Chang HC, Su KP, Wang F.

JAMA Netw Open. 2020 Oct 1;3(10):e2018777. doi: 10.1001/jamanetworkopen.2020.18777.

Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals

Lehmann S, Dumurgier J, Ayrignac X, Marelli C, Alcolea D, Ormaechea JF, Thouvenot E, Delaby C, Hirtz C, Vialaret J, Ginestet N, Bouaziz-Amar E, Laplanche JL, Labauge P, Paquet C, Lleo A, Gabelle A; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Alzheimers Res Ther. 2020 Oct 2;12(1):123. doi: 10.1186/s13195-020-00696-1.

Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis

Czakó C, Kovács T, Ungvari Z, Csiszar A, Yabluchanskiy A, Conley S, Csipo T, Lipecz A, Horváth H, Sándor GL, István L, Logan T, Nagy ZZ, Kovács I.

Geroscience. 2020 Dec;42(6):1499-1525. doi: 10.1007/s11357-020-00252-7. Epub 2020 Oct 4.

The Dual Role of Glutamatergic Neurotransmission in Alzheimer's Disease: From Pathophysiology to Pharmacotherapy

Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K, Orkisz S, Beggiato S, Serviddio G, Cassano T.

Int J Mol Sci. 2020 Oct 9;21(20):7452. doi: 10.3390/ijms21207452.

Serum Repressor Element-1 Silencing Transcription Factor Levels in Alzheimer's Patients from a National Institute of Health in Mexico City, Elderly and Young Controls

Ramírez-Cuapio FL, Torres-Ramos MA, Orozco-Ibarra M, Acosta I, Sosa-Ortiz AL.

Rev Invest Clin. 2020 May 7;73(1):017-022. doi: 10.24875/RIC.20000089.

β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification

Hampel H, Lista S, Vanmechelen E, Zetterberg H, Giorgi FS, Galgani A, Blennow K, Caraci F, Das B, Yan R, Vergallo A; Alzheimer’s Precision Medicine Initiative (APMI).

Alzheimers Res Ther. 2020 Oct 16;12(1):130. doi: 10.1186/s13195-020-00686-3.

Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer's Disease

Atlante A, Amadoro G, Bobba A, Latina V.

Cells. 2020 Oct 23;9(11):2347. doi: 10.3390/cells9112347.

CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment

Gaetani L, Paolini Paoletti F, Bellomo G, Mancini A, Simoni S, Di Filippo M, Parnetti L.

Trends Pharmacol Sci. 2020 Dec;41(12):1023-1037. doi: 10.1016/j.tips.2020.09.011. Epub 2020 Oct 27.

Applications of iTRAQ and TMT Labeling Techniques to the Study of Neurodegenerative Diseases

Li K, Chen Z, Zhang Y, Yang X.

Curr Protein Pept Sci. 2020;21(12):1202-1217. doi: 10.2174/1389203721666201103085704.

Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer's Disease: A Systematic Review and Meta-Analysis

Dulewicz M, Kulczyńska-Przybik A, Mroczko B.

Int J Mol Sci. 2020 Nov 6;21(21):8335. doi: 10.3390/ijms21218335.

Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer's disease created by integrative analysis of multi-omics data

Shigemizu D, Akiyama S, Higaki S, Sugimoto T, Sakurai T, Boroevich KA, Sharma A, Tsunoda T, Ochiya T, Niida S, Ozaki K.

Alzheimers Res Ther. 2020 Nov 10;12(1):145. doi: 10.1186/s13195-020-00716-0.

Clinical Utility of the Pathogenesis-Related Proteins in Alzheimer's Disease

Zhou B, Fukushima M.

Int J Mol Sci. 2020 Nov 17;21(22):8661. doi: 10.3390/ijms21228661.

Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer's Disease

Arastoo M, Lofthouse R, Penny LK, Harrington CR, Porter A, Wischik CM, Palliyil S.

Int J Mol Sci. 2020 Nov 17;21(22):8673. doi: 10.3390/ijms21228673.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias